Verve Therapeutics Inc (VERV) is around the middle of the Biotechnology industry according to InvestorsObserver. VERV received an overall rating of 41, which means that it scores higher than 41 percent of all stocks. Verve Therapeutics Inc also achieved a score of 44 in the Biotechnology industry, putting it above 44 percent of Biotechnology stocks. Biotechnology is ranked 49 out of the 148 industries.
VERV has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on VERV!